EMD
EMYRIAL FPO [EMD]
Healthcare · ASX Small Cap
$0.0520 -1.9%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +9First seen: 2026-02-25
Score Breakdown
Technical49
Catalyst50
Sentiment50
Fundamental65
Momentum76
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Strong cash runway (11 quarters)
- Strong revenue growth (+136%)
- Small-cap ($20-100M)
- Strong 12-1 momentum (+84%)
- Strong revenue momentum (+136%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Deeply negative margins (-199%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Record Half-Year Performance and National Expansion
NONE Appendix 4D and Half Year End Financial Report
NONE Application for quotation of securities - EMD
Recent ASX Announcements
| 2026-02-26 | Record Half-Year Performance and National Expansion |
| 2026-02-26 | Appendix 4D and Half Year End Financial Report PRICE SENSITIVE |
| 2026-02-16 | Application for quotation of securities - EMD |
| 2026-02-15 | Medibank Expands Funding to Emyria's Victorian Clinic PRICE SENSITIVE |
| 2026-02-12 | Emyria Expands Investor Access Into Europe |
Key Metrics
$42.7M
Market Cap
930K
Avg Volume
0.3x
Vol Ratio
$0.02 — $0.08
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-58.6%
ROE
-198.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 61% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #38 of 119 · Sector avg: 51
View all Healthcare signals →